Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep 18;7(11):769-78.
doi: 10.1038/nchembio.662.

Ligand discovery from a dopamine D3 receptor homology model and crystal structure

Affiliations

Ligand discovery from a dopamine D3 receptor homology model and crystal structure

Jens Carlsson et al. Nat Chem Biol. .

Abstract

G protein-coupled receptors (GPCRs) are intensely studied as drug targets and for their role in signaling. With the determination of the first crystal structures, interest in structure-based ligand discovery increased. Unfortunately, for most GPCRs no experimental structures are available. The determination of the D(3) receptor structure and the challenge to the community to predict it enabled a fully prospective comparison of ligand discovery from a modeled structure versus that of the subsequently released crystal structure. Over 3.3 million molecules were docked against a homology model, and 26 of the highest ranking were tested for binding. Six had affinities ranging from 0.2 to 3.1 μM. Subsequently, the crystal structure was released and the docking screen repeated. Of the 25 compounds selected, five had affinities ranging from 0.3 to 3.0 μM. One of the new ligands from the homology model screen was optimized for affinity to 81 nM. The feasibility of docking screens against modeled GPCRs more generally is considered.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Predicted Structure of the Dopamine D3 Receptor Binding Site
(a) Comparison of the homology model of the dopamine D3 receptor in complex with eticlopride (light blue) to the crystal structure (yellow) visualized with PyMOL. The structures have been aligned using 15 binding site residues. Polar interactions for the crystal structure are shown in black dotted lines. (b) Chemical structure of eticlopride (compound 1).
Figure 1
Figure 1. Predicted Structure of the Dopamine D3 Receptor Binding Site
(a) Comparison of the homology model of the dopamine D3 receptor in complex with eticlopride (light blue) to the crystal structure (yellow) visualized with PyMOL. The structures have been aligned using 15 binding site residues. Polar interactions for the crystal structure are shown in black dotted lines. (b) Chemical structure of eticlopride (compound 1).
Figure 2
Figure 2. Predicted binding modes of ligands found from the homology model screen
Predicted binding poses for four ligands discovered in the docking screen against the dopamine D3 receptor homology model, visualized with UCSF Chimera: (a) 3 (b) 4 (c) 6 (d) 7 Predicted binding modes for the two analogs of compound 3 based on docking to the homology model (e) 56 and (f) 57.
Figure 3
Figure 3. Dose-response curves of discovered ligands
Representative radioligand ([3H]N-methylspiperone) competition binding isotherms for compounds 3, 4, 7, 28, 30 and 31 (a-f). Data for a reference compound (chlorpromazine, black curve) are shown along with data for the test compound (red curve). Assays are performed using a final radioligand concentration between (0.5 × KD) and (1 × KD), where KD equals the radioligand dissociation constant, which is determined for each crude membrane preparation by radioligand saturation binding analysis. Data represent mean values ± standard error, performed on triplicate experiments.
Figure 4
Figure 4. Predicted binding modes of ligands found from the crystal structure screen
Predicted binding poses for the ligands discovered in the docking screen against the dopamine D3 receptor crystal structure, visualized with UCSF Chimera: (a) 28 (b) 29 (c) 31 (d) 32.

References

    1. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov. 2006;5:993–996. - PubMed
    1. Cherezov V, et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor. Science. 2007;318:1258–1265. - PMC - PubMed
    1. Warne T, et al. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature. 2008;454:486–491. - PMC - PubMed
    1. Jaakola VP, et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science. 2008;322:1211–1217. - PMC - PubMed
    1. Carlsson J, et al. Structure-Based Discovery of A2A Adenosine Receptor Ligands. J Med Chem. 2010;53:3748–3755. - PMC - PubMed

Publication types

Associated data